Baziel G M van Engelen Selected Research

Brachial Plexus Neuritis (Parsonage Turner Syndrome)

1/2020	Altered sensorimotor representations after recovery from peripheral nerve damage in neuralgic amyotrophy.
6/2011	Screening for antecedent Campylobacter jejuni infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baziel G M van Engelen Research Topics

Disease

9	Myotonic Dystrophy (Dystrophia Myotonica) 03/2022 - 05/2005
7	Facioscapulohumeral Muscular Dystrophy 01/2021 - 06/2012
6	Neuromuscular Diseases (Neuromuscular Disease) 10/2019 - 05/2007
5	Polymyositis 01/2018 - 01/2006
5	Myositis (Idiopathic Inflammatory Myopathies) 01/2018 - 01/2002
4	Muscular Dystrophies (Muscular Dystrophy) 08/2021 - 04/2013
4	Muscular Diseases (Myopathy) 08/2020 - 05/2015
4	Inclusion Body Myositis 01/2018 - 03/2002
4	Dermatomyositis (Dermatopolymyositis) 01/2018 - 01/2006
4	Disease Progression 01/2018 - 03/2002
3	Oculopharyngeal Muscular Dystrophy 08/2020 - 06/2013
3	Fatigue 10/2019 - 06/2010
3	Hearing Loss (Hearing Impairment) 11/2018 - 12/2017
3	Myotonia 03/2015 - 08/2008
3	Muscle Weakness 10/2013 - 03/2002
2	Brachial Plexus Neuritis (Parsonage Turner Syndrome) 01/2020 - 06/2011
2	Rare Diseases (Rare Disease) 12/2018 - 03/2015
2	Pain (Aches) 01/2018 - 07/2009
2	Congenital Disorders of Glycosylation 08/2016 - 02/2007
2	Mitochondrial Myopathies (Mitochondrial Myopathy) 07/2013 - 04/2008
2	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 04/2011 - 11/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2021
1	Paralysis (Palsy) 12/2021
1	merosin negative Muscular dystrophy congenital 08/2021
1	Sudden Infant Death (SID) 01/2021
1	Guillain-Barre Syndrome 01/2021
1	Deglutition Disorders (Dysphagia) 08/2020
1	Nondystrophic myotonia 12/2018
1	Epilepsy (Aura) 11/2018
1	Intellectual Disability (Idiocy) 11/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2018
1	Sarcoglycanopathies 01/2018
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 08/2016
1	Radiculopathy (Radiculopathy, Cervical) 01/2016
1	Avitaminosis (Vitamin Deficiency) 01/2016
1	Overweight 01/2016
1	Muscle Cramp (Cramp) 01/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2015
1	Channelopathies 01/2015
1	Edema (Dropsy) 01/2014
1	Atrophic Muscular Disorders 07/2013
1	Glycogen Storage Disease Type II (Pompe's Disease) 09/2012
1	Infections 06/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 08/2016 - 12/2010
4	Biomarkers (Surrogate Marker)IBA 03/2022 - 11/2018
4	AutoantibodiesIBA 01/2021 - 01/2002
3	AntibodiesIBA 01/2021 - 06/2011
3	RNA (Ribonucleic Acid)IBA 01/2019 - 04/2010
2	Albuterol (Salbutamol)FDA LinkGeneric 12/2021 - 07/2013
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 04/2013
2	Mexiletine (Mexitil)FDA LinkGeneric 12/2018 - 03/2015
2	Retinaldehyde (Retinal)IBA 11/2018 - 12/2017
2	EnzymesIBA 08/2016 - 09/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2009 - 01/2006
2	Prednisone (Sone)FDA LinkGeneric 07/2009 - 05/2009
2	Methotrexate (Mexate)FDA LinkGeneric 05/2009 - 03/2002
2	Creatine Kinase (Creatine Phosphokinase)IBA 07/2003 - 03/2002
1	Messenger RNA (mRNA)IBA 03/2022
1	Biological ProductsIBA 03/2022
1	Laminin (Merosin)IBA 08/2021
1	AntigensIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	MicroRNAs (MicroRNA)IBA 08/2020
1	Sarcoglycans (beta Sarcoglycan)IBA 01/2018
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	LipidsIBA 08/2016
1	Caffeine (No Doz)FDA LinkGeneric 01/2016
1	P-2 (P 2)IBA 01/2016
1	Coffee FDA Link 01/2016
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 09/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015
1	Amyloid (Amyloid Fibrils)IBA 05/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2015
1	Sodium Channels (Sodium Channel)IBA 01/2015
1	ChloridesIBA 01/2015
1	SodiumIBA 01/2015
1	Phosphocreatine (Neoton)IBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	Alanine (L-Alanine)FDA Link 07/2013
1	Poly(A)-Binding Protein IIIBA 07/2013
1	Poly(A)-Binding Proteins (Poly(A)-Binding Protein)IBA 06/2013
1	Complement System Proteins (Complement)IBA 03/2013
1	ChromatinIBA 06/2012
1	Rituximab (Mabthera)FDA Link 12/2011
1	MD1IBA 07/2011
1	GangliosidesIBA 06/2011

Therapy/Procedure

10	Therapeutics 12/2021 - 05/2005
2	Resistance Training 07/2013 - 09/2008
2	Enzyme Replacement Therapy 11/2012 - 09/2012
2	Physical Therapy Modalities (Physical Therapy Technique) 06/2010 - 05/2007
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Secondary Prevention 10/2019
1	Hearing Aids (Hearing Aid) 01/2018
1	Exercise Therapy (Therapy, Exercise) 01/2018
1	Drug Therapy (Chemotherapy) 05/2015
1	Enzyme Therapy 09/2012
1	Shared Medical Appointments 08/2011